Covid-19 Mass Vaccination Plan | Vaccines | Public Health

Uploaded by

Jeremy Turley

100% (1) 100% found this document useful (1 vote)

4K views

95 pages

Description:

covid vax plan

Date uploaded

Oct 19, 2020

Copyright

© © All Rights Reserved

Available Formats

PDF, TXT or read online from Scribd

Share this document

Did you find this document useful?

Is this content inappropriate?

Report this Document

100% (1) 100% found this document useful (1 vote)

4K views 95 pages

Uploaded by

Jeremy Turley

Description:

covid vax plan

Full description Jump to Page You are on page 1 of 95 Search inside document

  1

INTERIM DRAFT

NORTH DAKOTA COVID-19 VACCINATION PLAN

Updated October 16, 2020 Version 1.2

  2

Contents

Acronyms ......................................................................................................................................................... 6   Introduction .................................................................................................................................................... 7   Lessons Learned from H1N1 ................................................................................................................ 8   Response Goals for Pandemic Vaccination ................................................................................... 10   COVID-19 Mass Vaccination Planning Assumptions ............ ............. ............. ............. ............. . 11   Logistical Assumptions ......................................................................................................................... 12   Organizational Structure and Partner Involvement ................................................................... 13   Unified Command Planning Team ............................................................................................... 14   Internal COVID-19 Vaccination Planning Team ...................................................................... 14   Internal/External COVID-19 Vaccination Planning Committee ............ ............. ............. ... 14   CDC/HHS Microplanning ................................................................................................................ 14   Tabletop Exercises ............................................................................................................................. 15   Current Unknowns and Contingency Planning ........................................................................... 15   How persons who have tested positive for C OVID-19 will be prioritized. ............. ....... 15   Type of vaccine that will be available and cold chain requirements of vaccines. ....... 15   Potential adverse effects of a vaccine. ....................................................................................... 16   Vaccine amounts. ............................................................................................................................... 16   Vaccine Timing. ................................................................................................................................... 16   Use of adjuvant. .................................................................................................................................. 16   Multiple FDA approved products with different specifications. ..................... ............. ..... 17   Packaging. ............................................................................................................................................. 17   Current Significant Gaps ...................................................................................................................... 17   Provider Recruitment and Enrollment ................................................................................................. 19   Potential Providers ................................................................................................................................. 22   Vaccine Administration Capacity ...................................................................................................... 23   Vaccination of Out-of-State Residents ................................................................................................ 24     3 Vaccine Prioritization and Critical Populations ............ ............. .............. ............. ............. ............. ... 24   Critical infrastructure workforce ........................................................................................................ 25   People at increased risk for severe COVID-19 illness ............. ............. ............. ............. ............ 25   People at increased risk of acquiring or transmitting COVID-19 ............. ............. ............. ... 25   People with limited access to routine vaccination services .................................................... 25   Estimates of Priority Groups ............................................................................................................... 25   Vaccination of Special and Dependent Populations.................................................................. 28   Homebound ......................................................................................................................................... 28   Long Term Cares ................................................................................................................................ 29   Custodial institutions and special populations ....................................................................... 30   American Indians ................................................................................................................................ 31   New Americans/Foreign Born/Immigrant Populations .............. ............. ............. ............. ... 32   Priority Vaccination of Infrastructure .............................................................................................. 32   Advisory Committee on COVID-19 Vaccination E thics ............ ............. ............. .............. ......... 33   Vaccine Allocation....................................................................................................................................... 34   Vaccine Ordering and Processing ......................................................................................................... 35   Physical Vaccine Management and Cold Chain ............................................................................... 36   Management of Priority Vaccine Unstable at Zero Degrees or Higher ............ ............. ..... 36   Vaccine A: ....................................................................................................................................................... 36   Vaccine B: ....................................................................................................................................................... 36   Models for Distribution of Ultra-Cold Vaccine (Vaccine A) ..................... ............. ............. . 36   Three Phase Distribution .......................................................................................................................... 37   Scenarios for Vaccine Distribution ........................................................................................................ 40   Scenario 1 Background ......................................................................................................................... 40   Vaccine A: Ultra-cold with minimum quantity of 1,000 doses only................................. 40   Phase 2: General Public Added to Phase 1 Target Populations ............. ............. ............. . 43   Scenario 2 .................................................................................................................................................. 46   Vaccine B: Frozen va ccine only with minimum quantity of 100 doses ............. ............. . 46  
https://www.scribd.com/document/480713892/Covid-19-Mass-Vaccination-Plan#from_embed